Empresa Aptose Biosciences Nasdaq
Acciones
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
William Rice
CEO | Chief Executive Officer | 65 | 28/10/13 |
C. Payne
DFI | Director of Finance/CFO | 61 | 27/06/22 |
Chief Tech/Sci/R&D Officer | - | 01/11/19 | |
Rafael Bejar
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/01/20 |
Investor Relations Contact | - | - | |
Marc Wiles
LAW | General Counsel | - | - |
Brooks Ensign
AUD | Comptroller/Controller/Auditor | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Denis Burger
BRD | Director/Board Member | 80 | 19/09/07 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 13/09/22 |
Mark Vincent
BRD | Director/Board Member | 71 | 19/09/07 |
Director/Board Member | 74 | 15/12/14 | |
William Rice
CEO | Chief Executive Officer | 65 | 28/10/13 |
Warren Whitehead
BRD | Director/Board Member | 71 | 07/04/11 |
Carol Ashe
BRD | Director/Board Member | 66 | 15/08/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 16 309 393 | 13 210 854 ( 81,00 %) | 0 | 81,00 % |
Información de la empresa
Aptose Biosciences, Inc.
251 Consumers Road Suite 1105
M2J 4R3, Toronto
+647 479 9828
http://www.aptose.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
-0,09 % | 42,12 mil M | |
+49,62 % | 42,05 mil M | |
-4,96 % | 29,18 mil M | |
+11,18 % | 26,02 mil M | |
-21,95 % | 18,9 mil M | |
+8,61 % | 13,21 mil M | |
+24,73 % | 12,17 mil M | |
+28,31 % | 12,16 mil M | |
-6,26 % | 11,42 mil M |